Studies: Immunotherapies could change kidney cancer care
The way doctors typically approach kidney cancer treatment could be evolving.
Sections
Extras
Watch Now
The way doctors typically approach kidney cancer treatment could be evolving.
Combining an immunotherapy drug with chemotherapy nearly doubled the survival time of some lung cancer patients compared to patients treated with chemotherapy alone, new research published Monday in the New England Journal of Medicine showed.
The thought of a vaccine might conjure up memories of that flu shot you get each year, or taking your kids to get their immunizations against polio or measles. Cancer rarely comes to mind when most people think of vaccines, but that appears to be changing.
As promising as immunotherapy seems, could the spotlight on the treatment detract from other areas of cancer research?